What's New

Bug Fix

App Description

The American College of Cardiology’s AnticoagEvaluator is an easy and fast way to assess stroke and bleeding risk and the benefits and risks of antithrombotic therapy in patients with chronic atrial fibrillation.

• A combination risk calculator tool that uses CHADS2, CHA2DS2-VASc, and HAS-BLED
• Users can enter patient characteristics at the point of care and get individualized annual risk of ischemic stroke and thromboembolism with concurrent annual risk of major bleed
• Compare antithrombotic therapy options based on clinical trials (ACTIVE-A, RE-LY, ROCKET-AF, ARISTOTLE)

This app is adapted from a web tool created by Peter Loewen, B.Sc.(Pharm), ACPR, Pharm.D., FCSHP and can be viewed at http://www.sparctool.com/

iPhone Screenshots

(click to enlarge)

AnticoagEvaluator screenshot 1 AnticoagEvaluator screenshot 2 AnticoagEvaluator screenshot 3 AnticoagEvaluator screenshot 4

iPad Screenshots

(click to enlarge)

AnticoagEvaluator screenshot 5 AnticoagEvaluator screenshot 6 AnticoagEvaluator screenshot 7 AnticoagEvaluator screenshot 8 AnticoagEvaluator screenshot 9

App Changes

  • March 07, 2013 Initial release
  • June 05, 2013 New version 1.1
  • July 14, 2014 New version 1.3
  • August 16, 2014 New version 1.3.59
  • December 12, 2014 New version 1.4
  • December 15, 2014 New version 1.4.1

Other Apps From American College of Cardiology

JACC Journals CardioSource WorldNews CardioSmart Med Reminder ACC Connect American College of Cardiology Courses CardioSmart Explorer for Members CardioSmart Explorer for Everyone ACC.14 eMeeting Planner ASCVD Risk Estimator ACC Advocacy Action ACC Guideline Clinical App ACC.15 eMeeting Planner ACC FOCUS Statin Intolerance